Clinical Trial: Phase 1 Study Involving SAB01 and Healthy Participants

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07815561) titled 'Phase 1 Study Involving SAB01 and Healthy Participants' on Sept. 02.

Brief Summary: SAB01 is an investigational bispecific monoclonal antibody targeting mast cells. This first-in-human Phase 1 clinical trial evaluates the safety, pharmacokinetics, and pharmacodynamics of single ascending doses of SAB01 in healthy adult participants.

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: Subcutaneous (SC) single dose of SAB01

Single-dose administration of SAB01 by SC administration.

DRUG: Intravenous (IV) infusion of SAB01

Intravenous doses of SAB01 via IV infusion.

D...